BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34576081)

  • 1. The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension.
    Karoor V; Strassheim D; Sullivan T; Verin A; Umapathy NS; Dempsey EC; Frank DN; Stenmark KR; Gerasimovskaya E
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension.
    Lan B; Hayama E; Kawaguchi N; Furutani Y; Nakanishi T
    PLoS One; 2015; 10(1):e0117211. PubMed ID: 25629315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
    Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.
    Honda Y; Kosugi K; Fuchikami C; Kuramoto K; Numakura Y; Kuwano K
    PLoS One; 2020; 15(10):e0240692. PubMed ID: 33057388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV delivery of tumor necrosis factor-α short hairpin RNA attenuates cold-induced pulmonary hypertension and pulmonary arterial remodeling.
    Crosswhite P; Chen K; Sun Z
    Hypertension; 2014 Nov; 64(5):1141-50. PubMed ID: 25185133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
    Beik A; Najafipour H; Joukar S; Rajabi S; Iranpour M; Kordestani Z
    Clin Exp Hypertens; 2021 Apr; 43(3):270-280. PubMed ID: 33322932
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.
    Christou H; Reslan OM; Mam V; Tanbe AF; Vitali SH; Touma M; Arons E; Mitsialis SA; Kourembanas S; Khalil RA
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L875-90. PubMed ID: 22287610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
    Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
    Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil protects against pulmonary hypertension induced by hypoxia in neonatal rats via activation of PPARγ‑mediated downregulation of TRPC.
    Huang W; Liu N; Tong X; Du Y
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34935055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration.
    Irwin DC; Baek JH; Hassell K; Nuss R; Eigenberger P; Lisk C; Loomis Z; Maltzahn J; Stenmark KR; Nozik-Grayck E; Buehler PW
    Free Radic Biol Med; 2015 May; 82():50-62. PubMed ID: 25656991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
    Markvardsen LK; Sønderskov LD; Wandall-Frostholm C; Pinilla E; Prat-Duran J; Aalling M; Mogensen S; Andersen CU; Simonsen U
    J Vasc Res; 2021; 58(4):237-251. PubMed ID: 33910208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
    Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension.
    Maston LD; Jones DT; Giermakowska W; Howard TA; Cannon JL; Wang W; Wei Y; Xuan W; Resta TC; Gonzalez Bosc LV
    Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L609-L624. PubMed ID: 28213473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-29a-3p attenuates hypoxic pulmonary hypertension by inhibiting pulmonary adventitial fibroblast activation.
    Luo Y; Dong HY; Zhang B; Feng Z; Liu Y; Gao YQ; Dong MQ; Li ZC
    Hypertension; 2015 Feb; 65(2):414-20. PubMed ID: 25421979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) in chronic hypoxia- and antigen-mediated pulmonary vascular remodeling.
    Angelini DJ; Su Q; Yamaji-Kegan K; Fan C; Skinner JT; Poloczek A; El-Haddad H; Cheadle C; Johns RA
    Respir Res; 2013 Jan; 14(1):1. PubMed ID: 23289668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt5a attenuates hypoxia-induced pulmonary arteriolar remodeling and right ventricular hypertrophy in mice.
    Jin Y; Wang W; Chai S; Liu J; Yang T; Wang J
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1742-51. PubMed ID: 25956683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects.
    Lahm T; Albrecht M; Fisher AJ; Selej M; Patel NG; Brown JA; Justice MJ; Brown MB; Van Demark M; Trulock KM; Dieudonne D; Reddy JG; Presson RG; Petrache I
    Am J Respir Crit Care Med; 2012 May; 185(9):965-80. PubMed ID: 22383500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension.
    Darwiche T; Collum SD; Bi W; Reynolds JO; Wilson C; Wareing N; Hernandez AM; Mertens TCJ; Zhou Z; Pandit LM; Karmouty-Quintana H
    Exp Physiol; 2019 Apr; 104(4):568-579. PubMed ID: 30663834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction.
    de Raaf MA; Schalij I; Gomez-Arroyo J; Rol N; Happé C; de Man FS; Vonk-Noordegraaf A; Westerhof N; Voelkel NF; Bogaard HJ
    Eur Respir J; 2014 Jul; 44(1):160-8. PubMed ID: 24791833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.